BLFS
BioLife Solutions Inc
38.60$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 28.4% | 29.2% | 27.8% | 23.5% | 23.4% | 37.2% | 33.2% | 32.4% | 32.3% | 33.6% | 33.2% | 30.2% | |
| 4.7% | 6.8% | 7.4% | 5.9% | 6.3% | 23.9% | 16.9% | 8.2% | 7.5% | 8.1% | 5.7% | 5.4% | |
| 10.0% | 10.7% | 11.3% | 9.1% | 9.0% | 26.2% | 22.4% | 21.1% | 20.1% | 21.9% | 20.2% | 18.4% | |
| 6.0% | 4.5% | 4.6% | 4.8% | 4.7% | 2.3% | 2.3% | 2.6% | 2.8% | 2.0% | 3.3% | 2.4% | |
| 10.5% | 10.5% | 10.8% | 8.7% | 8.4% | 7.3% | 7.0% | 7.2% | 7.1% | 7.4% | 8.2% | 8.0% | |
| 54.7% | 54.5% | 56.0% | 59.9% | 58.9% | 53.1% | 53.7% | 54.8% | 54.1% | 51.4% | 52.0% | 46.6% | |
| 5.4% | 5.1% | 5.0% | 5.2% | 4.8% | 2.4% | 2.2% | 2.1% | 1.9% | 1.0% | 1.0% | 0.8% | |
| 19.2% | 18.2% | 17.0% | 14.3% | 14.7% | 12.7% | 10.8% | 10.4% | 9.8% | 8.4% | 7.2% | 6.1% | |
| 10.4% | 10.2% | 9.6% | 8.2% | 8.4% | 8.2% | 7.0% | 7.3% | 6.9% | 5.7% | 4.6% | 3.1% | |
| 2.0% | 1.8% | 2.9% | 3.6% | 4.0% | 3.1% | 3.1% | 3.2% | 2.5% | 1.8% | 1.2% | 0.6% | |
| 2.9% | 1.7% | 1.2% | 1.1% | 1.0% | 0.9% | 0.8% | 0.8% | 0.7% | 0.4% | 0.9% | 0.6% | |
| 5.1% | 4.4% | 3.9% | 2.8% | 2.0% | 1.3% | 0.6% | – | – | – | – | – | |
| 80.8% | 81.8% | 83.0% | 85.7% | 85.3% | 87.3% | 89.2% | 89.6% | 90.2% | 91.6% | 92.8% | 93.9% | |
| -73.0% | -75.9% | -81.0% | -92.2% | -91.1% | -83.9% | -84.9% | -90.7% | -89.5% | -83.7% | -84.4% | -65.6% | |
| 10.6% | 10.6% | 11.3% | 12.3% | 12.1% | 12.0% | 11.9% | 12.3% | 12.4% | 12.0% | 12.3% | 11.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.